522 results match your criteria: "Shimizu Hospital[Affiliation]"
J Clin Neurosci
January 2025
Department of Neurovascular Research, Kobe City Medical Center General Hospital, 2-1-1 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan; Department of Neurosurgery, Seijinkai Shimizu Hospital, 11-2 Yamadanakayoshimicho, Nishikyo-ku, Kyoto, Japan.
Background: Past studies have reported that vertebrobasilar dolichoectasia (VBD) patients may develop similar arteriopathies other than the vertebrobasilar system. However, the details of these VBD-related arteriopathies are still unclear.
Methods: We retrospectively enrolled patients diagnosed with VBD at two stroke centers in Japan between January 2012 and December 2023.
Respir Investig
January 2025
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan.
Background: Progressive pulmonary fibrosis (PPF) is a critical concern in interstitial lung disease (ILD) management. The HAL score, which incorporates honeycombing (H), age >75 years (A), and serum lactate dehydrogenase >222 U/L (L), can predict acute exacerbations in patients with idiopathic interstitial pneumonia (IIP). This study aims to evaluate the predictive utility of the HAL score for PPF development.
View Article and Find Full Text PDFJ Clin Med
December 2024
Department of Neurosurgery, Myodani Hospital, Kobe 655-0852 Hyogo, Japan.
Carotid artery stenting (CAS) has traditionally been performed using the transfemoral approach (TFA). Recently, the transradial approach (TRA) has gained attention for its lower invasiveness and reduced complication risk. This study compares outcomes between two access strategy timeframes, TFA-first and TRA-first, to evaluate how this shift influences outcomes in a real-world setting.
View Article and Find Full Text PDFFront Neurol
November 2024
Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.
Hinyokika Kiyo
October 2024
The Department of Pathology, Numazu City Hospital.
A 50-year-old woman presented to our hospital in May2021 with a fever of approximately39 °C and abdominal pain. A contrast-enhanced computed tomography (CT) scan revealed an 88 mm right renal tumor. Two weeks later, a follow-up CT scan demonstrated rapid tumor growth, with the major axis measuring 100 mm.
View Article and Find Full Text PDFStroke
December 2024
Department of Neurosurgery, Seijinkai Shimizu Hospital, Kyoto, Japan (N.S.).
Background: Restenosis after carotid artery stenting (CAS) is associated with the risk of developing ischemic stroke. We aimed to evaluate the inhibitory effect of cilostazol addition on in-stent restenosis (ISR) in patients treated with CAS.
Methods: In a randomized, open-label, blind-end point trial, patients with symptomatic and asymptomatic carotid artery stenosis and scheduled for CAS were randomly assigned to adding cilostazol (50 or 100 mg, twice per day) on other antiplatelets from 3 days before CAS or not adding cilostazol.
Front Neurol
October 2024
Department of Neurology, NHO Osaka National Hospital, Osaka, Japan.
Background: The addition of antiplatelet therapy to anticoagulant therapy in patients with stroke with non-valvular atrial fibrillation (NVAF) and atherothrombotic disease may increase bleeding risk without reducing recurrent stroke risk.
Aims: To evaluate the clinical benefits of anticoagulant monotherapy compared to combination therapy with anticoagulants and antiplatelet agents.
Methods And Design: This is an investigator-initiated prospective multicenter, randomized, open-label, parallel-group clinical trial.
J Am Acad Dermatol
November 2024
Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Respir Investig
November 2024
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
Background: Constipation is associated with the prognosis of several chronic diseases. However, the effect of constipation on the prognosis of idiopathic interstitial pneumonias (IIPs) remains unclear. This study aimed to investigate the association between constipation and the prognosis of patients with IIPs.
View Article and Find Full Text PDFJ Neurosurg
October 2024
18Department of Neurosurgery, National Cerebral and Cardiovascular Center Hospital, Suita.
Objective: Rupture of cerebral aneurysms has a poor prognosis, and growing aneurysms are prone to rupture. Although the number of coil embolization procedures is increasing worldwide, they are more prone to recurrence than clipping surgeries. However, there is still no drug that prevents aneurysm growth or recanalization after coil embolization.
View Article and Find Full Text PDFUltrasound Med Biol
January 2025
Department of Rehabilitation Science, Graduate School of Health Sciences, Josai International University, Togane, Chiba, Japan; Department of Physical Therapy, Faculty of Social Work Studies, Josai International University, Togane, Chiba, Japan; Department of Rehabilitation, Rakusai Shimizu Hospital, Kyoto, Japan.
J Neurointerv Surg
October 2024
Neurovascular Research, Kobe City Medical Center General Hospital, Kobe, Japan.
BMC Pulm Med
October 2024
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
Respir Res
September 2024
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Neurosurgery
September 2024
Department of Neurosurgery, Seijinkai Shimizu Hospital, Kyoto, Japan.
Background And Objectives: Endovascular treatment (EVT) for medium vessel occlusion (MeVO) raises concern about hemorrhagic complications; however, its clinical impact has not been elucidated. Therefore, we investigated the association between intracranial hemorrhage (ICH) after EVT for MeVO and functional outcomes.
Methods: We conducted a post hoc analysis of the Japan Registry of NeuroEndovascular Therapy 4, a nationwide registry in Japan from 2015 to 2019 including 13 479 patients who underwent EVT for acute ischemic stroke.
J Phys Ther Sci
September 2024
Department of Rehabilitation, Shiraishi Clinic Orthopedics & Internal Medicine & Gastrointestinal Medicine, Japan.
J Atheroscler Thromb
August 2024
Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center.
Vaccine
October 2024
Keio Pediatric Influenza Research Group, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Background: The annual administration of the influenza vaccine is the most effective method for preventing influenza. We have evaluated the effectiveness of the inactivated influenza vaccine in children aged 6 months to 15 years across the seasons from 2013/2014 to 2022/2023. This study aims to investigate the effectiveness of the inactivated influenza vaccine in the 2023/2024 season, the first year following the easing of strict COVID-19 measures, and possibly the last season when only the inactivated vaccine is available on the market.
View Article and Find Full Text PDFInterv Neuroradiol
August 2024
Division of Interventional Neuroradiology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
AJNR Am J Neuroradiol
November 2024
From the Department of Neurosurgery (M.B., K.U., F.S., M.S., S.Y.), Hyogo Medical University, Nishinomiya, Japan.
Background And Purpose: Reocclusion after treatment is a concern in endovascular therapy for isolated intracranial atherothrombotic stroke-related large-vessel occlusion (AT-LVO). However, the optimal endovascular therapy technique for AT-LVO has not yet been investigated. This study evaluated the optimal endovascular therapy technique for AT-LVO in a real-world setting.
View Article and Find Full Text PDFFront Neurol
June 2024
Department of Neurology, Nippon Medical School, Tokyo, Japan.
Neurol Med Chir (Tokyo)
August 2024
Department of Neurosurgery, Seijinkai Shimizu Hospital.
We reported the main results of the Japanese Registry of Neuroendovascular Therapy (JR-NET) 4, a nationwide surveillance of therapy (NET) in Japan from January 2015 to December 2019. JR-NET 4 registered consecutive patients who underwent NETs by Japan Society of Neuroendovascular Therapy (JSNET) -certified specialists. The primary endpoint was functional independence (mRS score of 0-2) at 30 days post-NET, with secondary endpoints focusing on technical success and major adverse events within 30 days.
View Article and Find Full Text PDFJ Clin Oncol
August 2024
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Purpose: We evaluated the efficacy and safety of antiemetic therapy with olanzapine, a neurokinin-1 receptor antagonist (RA), a 5-hydroxytryptamine-3 (5-HT) RA, and dexamethasone for preventing chemotherapy-induced nausea and vomiting in patients receiving carboplatin-containing chemotherapy.
Patients And Methods: Chemotherapy-naïve patients scheduled to receive carboplatin (AUC ≥5) were randomly assigned to receive either olanzapine 5 mg once daily (olanzapine group) or placebo (placebo group) in combination with aprepitant, a 5-HT RA, and dexamethasone. The primary end point was the complete response (CR; no vomiting and no rescue therapy) rate in the overall phase (0-120 hours).